Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche applies for Avastin advanced breast cancer use
Reuters
Tuesday, November 17, 2009 - 10:45am
tags:
Avastin, Roche, breast cancer, Genentech
Novartis: Smaller flu-vaccine doses suffice
Marketwatch
Tuesday, November 17, 2009 - 10:32am
tags:
Flu, vaccines, Novartis, H1N1
As Tax Breaks for Pfizer End, Jobs Disappear
BNET Pharma
Tuesday, November 17, 2009 - 9:56am
tags:
Pfizer, layoffs
Bristol Exchange Eases Downsizing
NY Times, NY
Tuesday, November 17, 2009 - 9:39am
tags:
Bristol-Myers Squibb, Mead Johnson
Mead Johnson May Become Bid Target for Danone, Nestle, Heinz
Bloomberg
Tuesday, November 17, 2009 - 9:18am
tags:
Mead Johnson, Bristol-Myers Squibb, M&A, infant formula
New Vaccine Questioned (Pfizer)
WSJ Online
Tuesday, November 17, 2009 - 9:10am
tags:
Pfizer, vaccines, Prevnar, pneumococcal disease, FDA
Merck shares rise as Wall Street brushes off study comparing cholesterol drugs Niaspan, Zetia
Yahoo/AP
Monday, November 16, 2009 - 6:44pm
tags:
Niaspan, Zetia, cholesterol, Merck, Abbott Laboratories
Getting to the Heart of the Merck-Abbott Embargo Break
CNBC
Monday, November 16, 2009 - 6:44pm
tags:
Merck, Abbott Laboratories, Vytorin, Niaspan
Bristol-Myers shares jump on news of Mead Johnson split
Marketwatch
Monday, November 16, 2009 - 6:43pm
tags:
Bristol-Myers Squibb, Mead Johnson
NeurogesX receives Food and Drug Administration approval for Qutenza pain patch
Yahoo/AP
Monday, November 16, 2009 - 5:36pm
tags:
FDA, pain patches, Qutenza, NeurogesX
Contamination Issues Haunt Genzyme
Yahoo/Zacks.com
Monday, November 16, 2009 - 11:08am
tags:
Genzyme
A Closer Look at Cardium's Wound-Healing Drug
TheStreet.com
Monday, November 16, 2009 - 11:07am
tags:
Cardium
Par Pharma gets FDA nod for generic version of Ultram
Reuters
Monday, November 16, 2009 - 10:41am
tags:
generics, Par Pharmaceutical, Ultram, painkillers
Bristol-Myers, Merck lead drug stocks higher
Marketwatch
Monday, November 16, 2009 - 10:35am
tags:
Merck, drug stocks, Bristol-Myers Squibb
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
InVivo
Monday, November 16, 2009 - 10:33am
tags:
Fate Therapeutics, Genzyme, Astellas
Human Genome's anthrax drug denied approval
Reuters
Monday, November 16, 2009 - 10:32am
tags:
anthrax, FDA, Human Genome Sciences
Cell Therapeutics Lavishes Free Stock on Execs
TheStreet.com
Monday, November 16, 2009 - 10:29am
tags:
Cell Therapeutics
An Odd Mix: Health Care Reform & Higher Rx Prices
Pharmalot
Monday, November 16, 2009 - 10:01am
tags:
healthcare reform, drug prices
Poniard Pharma says picoplatin did not improve survival in late stage study; shares tumble
Yahoo/AP
Monday, November 16, 2009 - 9:59am
tags:
Poniard, drug studies, cancer, picoplatin
[video] Cholesterol Drug Battle: Merck vs. Abbott Labs
CNBC
Monday, November 16, 2009 - 9:25am
tags:
Vytorin, Niaspan, Merck, cholesterol, Abbott Laboratories, Zetia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.